ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 61 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $10,000 | +11.1% | 17,124 | -10.0% | 0.00% | – |
| Q1 2020 | $9,000 | -97.8% | 19,025 | -97.2% | 0.00% | -100.0% |
| Q4 2019 | $414,000 | +44.8% | 685,000 | +37.0% | 0.00% | +100.0% |
| Q3 2019 | $286,000 | -94.8% | 500,000 | -89.8% | 0.00% | -93.3% |
| Q4 2015 | $5,513,000 | – | 4,913,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 9,821,000 | $11,314,000 | 1.07% |
| TFG Asset Management GP Ltd | 6,000,000 | $6,883,000 | 1.02% |
| Alken Asset Management Ltd | 400,000 | $461,000 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 6,525,000 | $7,470,000 | 0.54% |
| CSS LLC/IL | 8,000,000 | $9,158,000 | 0.51% |
| IRON Financial LLC | 505,000 | $578,000 | 0.28% |
| MACKAY SHIELDS LLC | 32,796,000 | $37,597,000 | 0.26% |
| OSTRUM ASSET MANAGEMENT | 400 | $459,000 | 0.22% |
| RWC Asset Management LLP | 4,400,000 | $5,037,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $5,580,000 | 0.16% |